Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety
- PMID: 19074583
- PMCID: PMC2659282
- DOI: 10.1210/en.2008-1045
Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety
Abstract
A physiological role in satiety is proposed for glucagon-like peptide-1 (GLP-1), secreted by the distal intestine in response to ingested nutrients. Here we report that in rats, ip injection of the GLP-1 receptor (GLP-1-R) antagonist exendin 9-39 (Ex9) elicited hyperphagia, but only at times of day when intake is otherwise low. Furthermore, ip administration of Ex9 attenuated satiety induced by either a voluntarily consumed sucrose meal (by 100%) or an intragastric glucose load (by 40%). To determine whether these effects involve blockade of GLP-1-R in brain or at a peripheral site, we injected Ex9 either centrally (into the third ventricle) or peripherally (ip) prior to GLP-1 injected either centrally or peripherally. Anorexia induced by peripheral GLP-1 was fully blocked by peripheral, but not central, pretreatment with Ex9, whereas the opposite was true for anorexic effect of central GLP-1. Thus, ip Ex9 appears to attenuate satiety via peripheral GLP-1-R blockade. Finally, anorexia induced by ip injection of exendin-4 (a GLP-1-R agonist) was due to both reduced meal size and increased duration between meals. We conclude that GLP-1 released from the intestine in response to ingested nutrients is a physiologically active satiety signal.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2659282/bin/zee0040946550001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2659282/bin/zee0040946550002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2659282/bin/zee0040946550003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2659282/bin/zee0040946550004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2659282/bin/zee0040946550005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2659282/bin/zee0040946550006.gif)
Similar articles
-
Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.Physiol Behav. 2011 Jul 6;103(5):557-64. doi: 10.1016/j.physbeh.2011.04.005. Epub 2011 Apr 15. Physiol Behav. 2011. PMID: 21515295 Free PMC article.
-
Nucleus accumbens GLP-1 receptors influence meal size and palatability.Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1314-20. doi: 10.1152/ajpendo.00137.2013. Epub 2013 Apr 23. Am J Physiol Endocrinol Metab. 2013. PMID: 23612998 Free PMC article.
-
Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.Endocrinology. 2011 Aug;152(8):3103-12. doi: 10.1210/en.2011-0174. Epub 2011 Jun 21. Endocrinology. 2011. PMID: 21693680 Free PMC article.
-
Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress.Neuropeptides. 1999 Oct;33(5):406-14. doi: 10.1054/npep.1999.0053. Neuropeptides. 1999. PMID: 10657518 Review.
-
The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.Minerva Endocrinol. 2002 Jun;27(2):79-93. Minerva Endocrinol. 2002. PMID: 11961501 Review.
Cited by
-
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.Physiol Behav. 2024 Jul 1;281:114565. doi: 10.1016/j.physbeh.2024.114565. Epub 2024 Apr 23. Physiol Behav. 2024. PMID: 38663460 Free PMC article. Review.
-
Incretin hormones and pharmacomimetics rapidly inhibit AgRP neuron activity to suppress appetite.bioRxiv [Preprint]. 2024 Mar 20:2024.03.18.585583. doi: 10.1101/2024.03.18.585583. bioRxiv. 2024. PMID: 38562891 Free PMC article. Preprint.
-
The chylomicron saga: time to focus on postprandial metabolism.Front Endocrinol (Lausanne). 2024 Jan 18;14:1322869. doi: 10.3389/fendo.2023.1322869. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38303975 Free PMC article. Review.
-
A New Dietary Fiber Can Enhance Satiety and Reduce Postprandial Blood Glucose in Healthy Adults: A Randomized Cross-Over Trial.Nutrients. 2023 Oct 27;15(21):4569. doi: 10.3390/nu15214569. Nutrients. 2023. PMID: 37960222 Free PMC article. Clinical Trial.
-
Roles of bile acids signaling in neuromodulation under physiological and pathological conditions.Cell Biosci. 2023 Jun 12;13(1):106. doi: 10.1186/s13578-023-01053-z. Cell Biosci. 2023. PMID: 37308953 Free PMC article. Review.
References
-
- Baggio LL, Drucker DJ 2007 Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131–2157 - PubMed
-
- Woods SC 2005 Signals that influence food intake and body weight. Physiol Behav 86:709–716 - PubMed
-
- Williams DL, Baskin DG, Schwartz MW 2006 Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 55:3387–3393 - PubMed
-
- Rodriquez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gomez R, Munoz RM, Eng J, Blazquez E 2000 Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 49:709–717 - PubMed
-
- Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath, MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69–72 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources